PAGANI, LISA
 Distribuzione geografica
Continente #
AS - Asia 3.350
NA - Nord America 2.916
EU - Europa 2.674
SA - Sud America 432
AF - Africa 73
OC - Oceania 17
Totale 9.462
Nazione #
US - Stati Uniti d'America 2.760
IT - Italia 1.186
SG - Singapore 957
VN - Vietnam 752
CN - Cina 663
HK - Hong Kong 412
RU - Federazione Russa 331
BR - Brasile 329
DE - Germania 294
IE - Irlanda 151
FR - Francia 137
GB - Regno Unito 115
SE - Svezia 106
CA - Canada 97
KR - Corea 87
IN - India 84
BD - Bangladesh 75
NL - Olanda 66
ES - Italia 57
ID - Indonesia 56
FI - Finlandia 55
AT - Austria 41
JP - Giappone 39
MX - Messico 34
ZA - Sudafrica 34
AR - Argentina 31
TR - Turchia 30
IQ - Iraq 29
CH - Svizzera 28
PL - Polonia 28
SA - Arabia Saudita 23
IR - Iran 22
PH - Filippine 22
PK - Pakistan 21
EC - Ecuador 20
AU - Australia 17
VE - Venezuela 14
CO - Colombia 13
LT - Lituania 13
UA - Ucraina 13
UZ - Uzbekistan 13
BE - Belgio 11
TW - Taiwan 10
CL - Cile 9
MA - Marocco 9
DK - Danimarca 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MY - Malesia 7
PY - Paraguay 6
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
JO - Giordania 4
LB - Libano 4
MN - Mongolia 4
MT - Malta 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MZ - Mozambico 1
Totale 9.457
Città #
Singapore 584
Ashburn 437
Milan 408
San Jose 404
Hong Kong 394
Ho Chi Minh City 239
Hanoi 208
Dallas 170
Frankfurt am Main 170
Dublin 149
Hefei 148
Los Angeles 129
New York 117
Santa Clara 94
Ann Arbor 85
Chandler 85
Seoul 79
Beijing 71
Chicago 66
The Dalles 61
Munich 50
Rome 49
Columbus 44
Council Bluffs 43
Shanghai 42
Buffalo 41
São Paulo 40
Boardman 38
Jakarta 38
Toronto 38
Lauterbourg 37
Da Nang 30
Moscow 30
Nuremberg 28
Kent 27
London 27
Montreal 26
Florence 25
Helsinki 25
Tokyo 25
Naples 24
Brooklyn 23
Orem 23
Denver 22
Haiphong 21
Amsterdam 20
Boston 20
Johannesburg 20
Hải Dương 19
Turku 19
Biên Hòa 18
Warsaw 18
Zurich 18
Can Tho 16
Madison 16
Sesto San Giovanni 16
Turin 15
Vienna 15
Chennai 14
Genoa 14
Poplar 14
Baghdad 13
Cinisello Balsamo 13
Ha Long 13
Paris 13
Ripalta Cremasca 13
Stockholm 13
Tashkent 13
Cagliari 12
Ninh Bình 12
Phoenix 12
Seregno 12
Busto Arsizio 11
Como 11
Houston 11
Mexico City 11
Monza 11
Quận Bình Thạnh 11
Rio de Janeiro 11
Riyadh 11
Romola 11
Atlanta 10
Bergamo 10
Pune 10
Ankara 9
Brussels 9
Carate Brianza 9
Guayaquil 9
Lahore 9
Melzo 9
Thái Nguyên 9
Düsseldorf 8
Guangzhou 8
Lappeenranta 8
Manchester 8
Newark 8
Princeton 8
San Francisco 8
Terni 8
Vercelli 8
Totale 5.589
Nome #
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 566
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 406
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 377
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 359
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 356
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 317
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 297
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 292
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 289
A molecular imaging approach to individuate tumour infiltrating lymphocytes 289
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 284
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 276
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 274
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 272
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 262
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 260
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 252
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 252
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 243
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 238
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 235
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 234
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 233
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 227
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 207
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 193
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 187
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 186
Tailored proteomic approaches based on nano-Liquid Chromatography-Mass Spectrometry to address biomedical challenging issues 182
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 172
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 171
Proteomic and glycoproteomic approaches based on nLC-ESI MS/MS for exploring cancer matrisome: explorative study 158
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 155
Proteomic characterization and comparison of human platelet lysates for a standardized and high quality production 145
Proteomic monitoring by label-free nLC-MS/MS of human platelet lysates for a standardized and optimized production 137
Deep proteome investigation in clinical studies: from the method development to its application 112
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination 94
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 89
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 87
N-Glycan profiling from DBS using the power of timsTOF fleX 64
Development and Validation of a nanoLC-TIMS-MS/MS Method for Structural Characterization of Plasma and DBS N-Glycans 35
SPATIAL MULTI-OMICS MALDI-MSI REVEALS MOLECULAR SIGNATURES ACROSS BREAST CANCER SUBTYPES 33
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicity 31
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 30
Using an integrated omics approach to uncover the mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN) 28
LC-MS/MS and SISCAPA Technology: A Novel Approach for Accurate Thyroglobulin Quantification Overcoming Antibody Interference 15
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 10
Spatial multi-omics insights into transplanted human thyroid organoid via spatial mass spectrometry imaging 8
Totale 9.619
Categoria #
all - tutte 29.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 8 30 21 19 0 9 7 7 24 30
2022/2023596 68 84 61 87 38 74 23 35 37 19 30 40
2023/2024733 19 22 27 84 64 188 114 39 50 16 35 75
2024/20252.259 72 169 142 111 218 106 158 72 234 387 215 375
2025/20265.843 958 396 492 699 457 295 829 177 365 503 268 404
2026/202733 33 0 0 0 0 0 0 0 0 0 0 0
Totale 9.619